logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
L

Lorenzo Trippa

dana-farber cancer institute

43H指数
353论文数
7.0K被引数
收录论文 78
发表时间
logo
Teclistamab versus lenalidomide-dexamethasone in high-risk smoldering multiple myeloma: a randomized phase 2 trialTeclistamab 与来那度胺-地塞米松在高风险冒烟型多发性骨髓瘤中的比较：一项随机II期试验
errNature Medicine
IF50
err2026-09-11
err0
errOAAI
errOmar Nadeem; David M. Cordas dos Santos; Sophie Magidson; Jeffrey Matous; Eva Medvedova; Elizabeth O’Donnell; Robert A. Redd; Yuxin Liu; Shonali Midha; Adam S. Sperling; Frances Arters; Christine Davie; Caroline Ricciardi; Rosa Toenges; Nayda Bidikian; Subear Hussein; Jean-Baptiste Alberge; Sungjae Kim; Lorena Pantano-Rubino; Francesco Corrado; Hannah Ashton; Daniel Addonizio; Siham Mohamed; Ashlee Sturtevant; Marjorie Marto; Amy Bergeron; Francesco Malfona; Kevin Panaro; Paul G. Richardson; Jerome Ritz; Lorenzo Trippa; Irene M. Ghobrial
err分享
err收藏
Macrophage reprogramming, not CD8 T cell dynamics, characterizes durable disease control following PD-1 blockade in smoldering myeloma巨噬细胞重编程，而非CD8 T细胞动力学，是PD-1阻断后冒烟性骨髓瘤获得持久疾病控制的特点
errLeukemia
IF13.4
err2026-09-03
err0
PREAI
errNoé Perron; Kane Foster; Tarek H. Mouhieddine; Robert A. Redd; Sophie Magidson; Jacqueline Perry; Ashlee Sturtevant; Christine Davie; Caroline Ricciardi; Frances Arters; Marjorie Marto; Amy Goguen; Yuxin Liu; Elizabeth K. O’Donnell; Adam S. Sperling; Jacob P. Laubach; Paul G. Richardson; Gad Getz; Romanos Sklavenitis-Pistofidis; Lorenzo Trippa; Yoshinobu Konishi; Omar Nadeem; Irene M. Ghobrial
err分享
err收藏
Risk-adapted therapy guided by human papillomavirus (HPV) circulating tumor DNA in HPV-positive oropharyngeal cancer (ReACT 1.0): an exploratory phase II trial人乳头瘤病毒（HPV）循环肿瘤DNA指导下的风险适应性疗法在HPV阳性口咽癌中的探索性II期试验（ReACT 1.0）
errNature Communications
IF15.7
err2026-05-07
err0
errOAAI
errGlenn J. Hanna; Tulika R. Gupta; Lorenzo Trippa; Eleni M. Rettig; Danielle N. Margalit; Roy B. Tishler; Itai Pashtan; Emily Kim; Alexander Droznin; Lauren Gunasti; Riley Maddox; Jacqueline Minken; Dev Mukundan; Kartik Sehgal; Michael J. Dennis; Thomas O’Connor; Jack M. Qian; Graham H. Boyd; Anurag Saraf; Daribelle Massiel Gil; Rosh K. Sethi; Donald J. Annino; Lauren A. Goguen; Jeffrey P. Guenette; Mina Bakhtiar; Vickie Y. Jo; Kristine Wong; Ravindra Uppaluri; Robert I. Haddad; Jonathan D. Schoenfeld
err分享
err收藏
Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trialCiltacabtagene autoleucel在高风险冒烟型多发性骨髓瘤中的应用：CAR-PRISM二期临床试验
errNature Medicine
IF50
err2026-04-20
err0
errOAAI
errOmar Nadeem; David M. Cordas dos Santos; Sarah Nikiforow; Anna Bosch-Vilaseca; Elizabeth O’Donnell; Robert Redd; Kevin C. DeBraganca; Adam S. Sperling; Yuxin Liu; Caleb McEntire; Frances Arters; Colin O’Donnell; Brendan Kineavy; Marjorie Marto; Amy Bergeron; Emilie Swenson; Kristin McHugh; Abigail Caron; Quentin Berry; Hope Wei; Emily Durlacher; Elizabeth Grimm; Francesco Corrado; Nayda Bidikian; Rocio Montes de Oca; Tamar Lengil; Denise De Wiest; Casey Gervais; Kevin Panaro; Eric L. Smith; Kenneth Anderson; Caron Jacobson; Nikhil C. Munshi; Paul Richardson; Deepu Madduri; Jordan M. Schecter; Craig Tendler; Mark A. Wildgust; Lorenzo Trippa; Maria Victoria Mateos; Jerome Ritz; Irene M. Ghobrial
err分享
err收藏
Daratumumab in high-risk MGUS and low-risk smoldering myeloma: results of the Phase II D-PRISM study达鲁珠单抗在高风险MGUS和低风险 smoldering myeloma 中的疗效：D-PRISM II期研究结果
errNature Communications
IF15.7
err2026-04-08
err0
errOAAI
errOmar Nadeem; Michelle P. Aranha; Robert A. Redd; Michael Koontz; Jeffrey V. Matous; Andrew J. Yee; Jeffrey A. Zonder; Andrew Kin; Sophie Magidson; Elizabeth D. Lightbody; Ting Wu; Floris Chabrun; Jean-Baptiste Alberge; Ankit K. Dutta; Jacqueline Perry; Ashlee Sturtevant; Mahshid Rahmat; Junko Tsuji; Christine Davie; Caroline Ricciardi; Frances Arters; Marjorie Marto; Amy Bergeron; Jacalyn Rosenblatt; Elizabeth K. O’Donnell; Tarek H. Mouhieddine; Lorena Pantano; Jacob P. Laubach; Paul G. Richardson; Gad Getz; Lorenzo Trippa; Romanos Sklavenitis-Pistofidis; Irene M. Ghobrial
err分享
err收藏
Enhanced dynamic risk stratification of smoldering multiple myeloma增强的冒烟性多发性骨髓瘤动态风险分层
errNature Medicine
IF50
err2026-03-01
err1
errOAAI
errChabrun, Floris; Schwartz, Daniel E.; Gentile, Susanna; Mai, Elias K.; Gupta, Tulika R.; Perry, Jacqueline; Cordas Dos Santos, David M.; Hielscher, Thomas; Werly, Annika; Schmidt, Sophia K.; Theodorakakou, Foteini; Fotiou, Despina; Liacos, Christine Ivy; Kanellias, Nikolaos; Gisbert, Noelia Collado; Martin-Sanchez, Esperanza; Termini, Rosalinda; Waldschmidt, Johannes; Chavda, Selina J.; Ainley, Louise; Da Via, Matteo Claudio; De Magistris, Claudio; Pettine, Loredana; Timonian, Michael A.; Alberge, Jean-Baptiste; Patel, Vidhi; Costello, Patrick; Tobia, Catherine; Phan, Sally; Lamb, Jennifer; Silverio, Maria-Theresa; Davis, Maya; O'donnell, Elizabeth K.; Marinac, Catherine R.; Nadeem, Omar; Bolli, Niccolo; Yong, Kwee; Kortum, K. Martin; Einsele, Hermann; Mateos, Maria-Victoria; Kumar, Shaji; San-Miguel, Jesus F.; Paiva, Bruno; Kastritis, Efstathios; Dimopoulos, Meletios A.; Raab, Marc S.; Trippa, Lorenzo; Ghobrial, Irene M.
err分享
err收藏
Leveraging external data for testing experimental therapies with biomarker interactions in randomized clinical trials利用外部数据测试具有生物标志物相互作用的随机临床试验中的实验性疗法
errBiometrika
IF2.8
err2026-01-01
err0
PREAI
errRen, B.; Ferrari, F.; Fortini, S.; Ventz, S.; Trippa, L.
err分享
err收藏
NERATINIB FORNF2-RELATED SCHWANNOMATOSIS WITH PROGRESSIVE TUMORS: INTERIM ANALYSIS FROM THE INTUITT-NF2 PLATFORM-BASKET TRIAL奈拉替尼用于NF2相关神经鞘瘤病伴进展性肿瘤：INTUITT-NF2平台篮式试验的期中分析
errNEURO-ONCOLOGY
IF13.4
err2025-11-01
err0
PREAI
errPlotkin, Scott; Nghiemphu, Phioanh; Yohay, Kaleb; Dinh, Christine; Merker, Vanessa; Fell, Geoffrey; Trippa, Lorenzo; Blakeley, Jaishri
err分享
err收藏
UPDATED RESULTS ON BRIGATINIB TREATMENT FOR PROGRESSIVE TUMORS IN PATIENTS WITHNF2-RELATED SCHWANNOMATOSIS: A SUB-STUDY OF THE INTUITT-NF2 TRIAL更新关于brigatinib治疗NF2相关神经鞘瘤病患者进展性肿瘤的疗效：INTUITT-NF2试验的亚组研究
errNEURO-ONCOLOGY
IF13.4
err2025-11-01
err0
errOAAI
errPlotkin, Scott; Yohay, Kaleb; Nghiemphu, Phioanh; Dinh, Christine; Babovic-Vuksanovic, Dusica; Merker, Vanessa; Bakker, Annette; Fell, Geoffrey; Trippa, Lorenzo; Blakeley, Jaishri
err分享
err收藏
Interpretable Model Summaries Using the Wasserstein Distance使用Wasserstein距离的可解释模型摘要
errAMERICAN STATISTICIAN
IF2.1
err2025-10-01
err0
PREAI
errDunipace, Eric; Trippa, Lorenzo
err分享
err收藏
Comparing Fourteen Behavioral Science Electronic Health Record Deprescribing Tools in Older Adults: NUDGE-EHR Adaptive Trial比较十四种行为科学电子健康记录停药工具在老年人中的应用：NUDGE-EHR适应性试验
errJournal of the American Geriatrics Society
IF4.5
err2025-07-04
err0
PREAI
errJulie C. Lauffenburger; Thomas Isaac; Lorenzo Trippa; Robert J. Glynn; Massimiliano Russo; Punam Keller; Ted Robertson; Dae H. Kim; Gauri Bhatkhande
err分享
err收藏
Bayesian multi-study non-negative matrix factorization for mutational signatures贝叶斯多研究非负矩阵分解用于突变特征
errGENOME BIOLOGY
IF9.4
err2025-04-16
err0
errOAAI
errGrabski, Isabella N.; Trippa, Lorenzo; Parmigiani, Giovanni
err分享
err收藏
Informative censoring in externally controlled clinical trials: a potential source of bias外部控制临床试验中的信息审查: 潜在的偏倚来源
errESMO OPEN
IF8.3
err2025-01-01
err0
errOAAI
errGupta, T. Rudra; Schwartz, D. E.; Saha, R.; Wen, P. Y.; Rahman, R.; Trippa, L.
err分享
err收藏
SAFETY LEAD-IN RESULTS FOR QBS10072S IN THE INDIVIDUAL SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGHT) TRIAL, A RANDOMIZED ADAPTIVE PLATFORM TRIAL FOR NEWLY DIAGNOSED MGMT UNMETHYLATED GLIOBLASTOMA
errNEURO-ONCOLOGY
IF13.4
err2024-11-11
err0
PREAI
errRahman, Rifaquat; Trippa, Lorenzo; Aquilanti, Elisa; Lee, Eudocia; Arrillaga-Romany, Isabel; Wiley, Jennifer; Chukwueke, Ugonma; McFaline-Figueroa, Jose; Partridge, Kathryn; Beroukhim, Rameen; Nayak, Lakshmi; Batchelor, Tracy; Lu-Emerson, Christine; Drappatz, Jan; Lassman, Andy; Welch, Mary; Ahluwalia, Manmeet; Bi, Wenya; Arnaout, Omar; Haas-Kogan, Daphne; Tanguturi, Shyam; Aizer, Ayal; Doherty, Lisa; Fell, Geoffrey; Lavallee, Maria; Smokovich, Anna; Peabody, Shannon; Westergaard, Catharina; Bhutani, Vasvi; Russ, Alyssa; Barlow, Brooke; Chiocca, Ennio; Ringold, Gordon; Weitzman, Ron; Holland, Jaymes; Reardon, David; Ligon, Keith; Wen, Patrick
err分享
err收藏
Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors布格替尼治疗NF2-Related神经鞘瘤病伴进行性肿瘤
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2024-06-27
err2
PREAI
errPlotkin, Scott R.; Yohay, Kaleb H.; Nghiemphu, Phioanh L.; Dinh, Christine T.; Babovic-Vuksanovic, Dusica; Merker, Vanessa L.; Bakker, Annette; Fell, Geoffrey; Trippa, Lorenzo; Blakeley, Jaishri O.
err分享
err收藏
Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trialsacituzumab govitecan治疗局部三阴性乳腺癌的新辅助治疗: 来自NeoSTAR试验的结果
errANNALS OF ONCOLOGY
IF65.4
err2024-03-01
err13
errOAAI
errSpring, L. M.; Tolaney, S. M.; Fell, G.; Bossuyt, V.; Abelman, R. O.; Wu, B.; Maheswaran, S.; Trippa, L.; Comander, A.; Mulvey, T.; McLaughlin, S.; Ryan, P.; Ryan, L.; Abraham, E.; Rosenstock, A.; Garrido-Castro, A. C.; Lynce, F.; Moy, B.; Isakoff, S. J.; Tung, N.; Mittendorf, E. A.; Ellisen, L. W.; Bardia, A.
err分享
err收藏
Clinical trials that leverage external data: Do we need more transparent protocols and statistical plans?
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2024-01-01
err0
PREAI
errSchwartz, Daniel Evan; Essaouabi, Hanna; Trippa, Lorenzo
err分享
err收藏
Looking ahead in early-phase trial design to improve the drug development process: examples in oncology
errBMC MEDICAL RESEARCH METHODOLOGY
IF3.4
err2023-06-29
err0
errOAAI
errVanderbeek, Alyssa M.; Redd, Robert A.; Ventz, Steffen; Trippa, Lorenzo
err分享
err收藏
Comment: Advancing Clinical Trials with Novel Designs and Implementations
errSTATISTICAL SCIENCE
IF3.4
err2023-05-01
err0
errOAAI
errTrippa, Lorenzo; Xu, Yanxun
err分享
err收藏
Cross-Study Replicability in Cluster Analysis
errSTATISTICAL SCIENCE
IF3.4
err2023-05-01
err2
errOAAI
errMasoero, Lorenzo; Thomas, Emma; Parmigiani, Giovanni; Tyekucheva, Svitlana; Trippa, Lorenzo
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
G
Gad Getz
H 指数: 248 · 论文数: 1.8K
R
Rakesh K. Jain
H 指数: 200 · 论文数: 1.7K
K
Kenneth C. Anderson
H 指数: 199 · 论文数: 3.1K
C
Charles M. Perou
H 指数: 193 · 论文数: 2.0K
E
Eric P. Winer
H 指数: 170 · 论文数: 1.6K
查看更多